"Ranolazine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acetanilide and piperazine derivative that functions as a SODIUM CHANNEL BLOCKER and prevents the release of enzymes during MYOCARDIAL ISCHEMIA. It is used in the treatment of ANGINA PECTORIS.
Descriptor ID |
D000069458
|
MeSH Number(s) |
D02.065.199.092.850 D02.092.146.113.092.850 D03.383.606.841
|
Concept/Terms |
Ranolazine- Ranolazine
- N-(2,6-dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-1-piperazineacetamide
- Renolazine
Ranolazine Hydrochloride- Ranolazine Hydrochloride
- Hydrochloride, Ranolazine
- Ranolazine Dihydrochloride
- Dihydrochloride, Ranolazine
- Ranolazine HCl
- HCl, Ranolazine
RS 43285- RS 43285
- 43285, RS
- RS-43285
- RS43285
|
Below are MeSH descriptors whose meaning is more general than "Ranolazine".
Below are MeSH descriptors whose meaning is more specific than "Ranolazine".
This graph shows the total number of publications written about "Ranolazine" by people in this website by year, and whether "Ranolazine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
2012 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ranolazine" by people in Profiles.
-
Open-label pilot study of ranolazine for cramps in amyotrophic lateral sclerosis. Muscle Nerve. 2022 07; 66(1):71-75.
-
Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal. Expert Opin Pharmacother. 2012 Dec; 13(17):2555-63.
-
Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group. Circulation. 1994 Aug; 90(2):726-34.